633 related articles for article (PubMed ID: 33315181)
1. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.
Seneviratne CJ; Balan P; Ko KKK; Udawatte NS; Lai D; Ng DHL; Venkatachalam I; Lim KS; Ling ML; Oon L; Goh BT; Sim XYJ
Infection; 2021 Apr; 49(2):305-311. PubMed ID: 33315181
[TBL] [Abstract][Full Text] [Related]
2. Mouth rinses efficacy on salivary SARS-CoV-2 viral load: A randomized clinical trial.
Alzahrani MM; Bamashmous S; Alkharobi H; Alghamdi A; Alharbi RH; Hassan AM; Darwish M; Bukhari A; Mahmoud AB; Alfaleh MA; Mirza AA; Abuzenadah AM; Abujamel TS; Hashem AM
J Med Virol; 2023 Jan; 95(1):e28412. PubMed ID: 36527332
[TBL] [Abstract][Full Text] [Related]
3. The short-term effect of different chlorhexidine forms versus povidone iodine mouth rinse in minimizing the oral SARS-CoV-2 viral load: An open label randomized controlled clinical trial study.
Natto ZS; Bakhrebah MA; Afeef M; Al-Harbi S; Nassar MS; Alhetheel AF; Ashi H
Medicine (Baltimore); 2022 Jul; 101(30):e28925. PubMed ID: 35905275
[TBL] [Abstract][Full Text] [Related]
4. Eligibility and efficacy of a CPC- and CHX-based antiviral mouthwash for the elimination of SARS-CoV-2 from the saliva: A randomized, double-blind, controlled clinical trial.
Brunello G; Wolf V; Kerberger R; Bernhard M; Lübke N; Becker J; Schwarz-Herzke B; Timm J; Becker K
J Clin Periodontol; 2024 Feb; 51(2):158-166. PubMed ID: 38058254
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2.
Ferrer MD; Barrueco ÁS; Martinez-Beneyto Y; Mateos-Moreno MV; Ausina-Márquez V; García-Vázquez E; Puche-Torres M; Giner MJF; González AC; Coello JMS; Rueda IA; Aubá JMV; Español CC; Velasco AL; Abad DS; García-Esteban S; Artacho A; López-Labrador X; Mira A
Sci Rep; 2021 Dec; 11(1):24392. PubMed ID: 34937855
[TBL] [Abstract][Full Text] [Related]
6. Oral mouthwashes for asymptomatic to mildly symptomatic adults with COVID-19 and salivary viral load: a randomized, placebo-controlled, open-label clinical trial.
Onozuka D; Takatera S; Matsuo H; Yoshida H; Hamaguchi S; Yamamoto S; Sada RM; Suzuki K; Konishi K; Kutsuna S
BMC Oral Health; 2024 Apr; 24(1):491. PubMed ID: 38664718
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of mouthrinses in reducing oral SARS-COV-2 load: a review.
Pannuti CM; Reis INRD; Souza NV; Souto MLS; Silva CGB; Bezinelli LM; Machado CM; Romito GA; Villar CC
Braz Oral Res; 2023; 37():e038. PubMed ID: 37132726
[TBL] [Abstract][Full Text] [Related]
8. Reduction of SARS-CoV-2 salivary viral load with pre-procedural mouth rinses: a randomised, controlled, clinical trial.
Farmaha JK; James JN; Frazier K; Sahajpal NS; Mondal AK; Bloomquist DT; Kolhe R; Looney SW; Bloomquist R
Br Dent J; 2023 Apr; 234(8):593-600. PubMed ID: 37117367
[TBL] [Abstract][Full Text] [Related]
9. Reduction of SARS-CoV-2 viral load in saliva after rinsing with mouthwashes containing cetylpyridinium chloride: a randomized clinical study.
Bezinelli LM; Corrêa L; Beyerstedt S; Franco ML; Rangel ÉB; Benítez CG; Hamerschlak N; Pinho JRR; Heller D; Eduardo FP
PeerJ; 2023; 11():e15080. PubMed ID: 38130922
[TBL] [Abstract][Full Text] [Related]
10. An exploratory study of drug concentration and inhibitory effect of cetylpyridinium chloride buccal tablets on SARS-CoV-2 infection among 10 Chinese subjects.
Li Y; Xie Z; Chen L; Liu X; Li S; Ye S; Tang H; Lee C; Gu Q; Men F; Zhang J; Hu D; Jiang Y; Wang X; Wang Q; Feng Y; Niu S; Liu Y; Fang Y
Fundam Clin Pharmacol; 2024 Jun; 38(3):579-587. PubMed ID: 37985697
[TBL] [Abstract][Full Text] [Related]
11. Randomized clinical trial to assess the impact of oral intervention with cetylpyridinium chloride to reduce salivary SARS-CoV-2 viral load.
Tarragó-Gil R; Gil-Mosteo MJ; Aza-Pascual-Salcedo M; Alvarez MJL; Ainaga RR; Gimeno NL; Viñuales RF; Fernández YM; Marco JM; Bolsa EA; Sancho JB; Cajo SA; Perez-Zsolt D; Raïch-Regué D; Muñoz-Basagoiti J; Izquierdo-Useros N; Pociello VB; León R; Peris DS
J Clin Periodontol; 2023 Mar; 50(3):288-294. PubMed ID: 36345827
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of mouth rinses against COVID-19: a systematic review and network meta-analysis.
Lin SY; Sun JS; Hung MC; Chang JZ
J Hosp Infect; 2023 Sep; 139():175-191. PubMed ID: 37419189
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot study.
Perussolo J; Teh MT; Gkranias N; Tiberi S; Petrie A; Cutino-Moguel MT; Donos N
Sci Rep; 2023 Aug; 13(1):12647. PubMed ID: 37542087
[TBL] [Abstract][Full Text] [Related]
14. Oral antiseptics against coronavirus: in-vitro and clinical evidence.
Mateos-Moreno MV; Mira A; Ausina-Márquez V; Ferrer MD
J Hosp Infect; 2021 Jul; 113():30-43. PubMed ID: 33865974
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial.
Elzein R; Abdel-Sater F; Fakhreddine S; Hanna PA; Feghali R; Hamad H; Ayoub F
J Evid Based Dent Pract; 2021 Sep; 21(3):101584. PubMed ID: 34479668
[TBL] [Abstract][Full Text] [Related]
16. Substantivity of mouth-rinse formulations containing cetylpyridinium chloride and O-cymen-5-ol: a randomized-crossover trial.
Aguilera FR; Viñas M; Sierra JM; Vinuesa T; R Fernandez de Henestrosa A; Furmanczyk M; Trullàs C; Jourdan E; López-López J; Jorba M
BMC Oral Health; 2022 Dec; 22(1):646. PubMed ID: 36575444
[TBL] [Abstract][Full Text] [Related]
17. Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial.
Eduardo FP; Corrêa L; Heller D; Daep CA; Benitez C; Malheiros Z; Stewart B; Ryan M; Machado CM; Hamerschlak N; Rebello Pinho JR; Bezinelli LM
Heliyon; 2021 Jun; 7(6):e07346. PubMed ID: 34189331
[TBL] [Abstract][Full Text] [Related]
18. Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial.
Carrouel F; Valette M; Gadea E; Esparcieux A; Illes G; Langlois ME; Perrier H; Dussart C; Tramini P; Ribaud M; Bouscambert-Duchamp M; Bourgeois D
Clin Microbiol Infect; 2021 Oct; 27(10):1494-1501. PubMed ID: 34044151
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of mouthwashes on reducing SARS-CoV-2 viral load in oral cavity: a systematic review and meta-analysis.
Ebrahimi T; Shamshiri AR; Alebouyeh M; Mohebbi SZ
BMC Oral Health; 2023 Jul; 23(1):443. PubMed ID: 37400836
[TBL] [Abstract][Full Text] [Related]
20. Reducing the viral load of SARS-CoV-2 in the saliva of patients with COVID-19.
Guimarães TC; Marques BBF; Castro MV; Secco DA; Porto LCMS; Tinoco JMM; Tinoco EMB; Fletcher P; Fischer RG
Oral Dis; 2022 Nov; 28 Suppl 2():2474-2480. PubMed ID: 34963033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
